Safety and Efficacy of Neoadjuvant Gemcitabine plus Carboplatin Followed by Immediate Cystectomy in Patients with Muscle-Invasive Bladder Cancer: A Propensity Score Analysis

被引：0

作者：

Koie, T. ^{[1
]}

Okamoto, A. ^{[1
]}

Tobisawa, Y. ^{[1
]}

Yoneyama, T. ^{[1
]}

Mori, K. ^{[1
]}

Yamamoto, H. ^{[1
]}

Hatakeyama, S. ^{[1
]}

Yoneyama, T. ^{[1
]}

Hashimoto, Y. ^{[1
]}

Ohyama, C. ^{[1
]}

机构：

[1] Hirosaki Univ, Grad Sch Med, Dept Urol, Hirosaki, Aomori, Japan

来源：

UROLOGY | 2012年 / 80卷 / 03期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

EP.044

引用

页码：S205 / S205

页数：1

共 50 条

[31] Comparison between neoadjuvant and adjuvant gemcitabine plus cisplatin chemotherapy for muscle-invasive bladder cancer [J].

Matsubara, Nobuaki ;

Mukai, Hirofumi ;

Naito, Yoichi ;

Nezu, Masahiko ;

Itoh, Kuniaki .

ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2013, 9 (04) :310-317

[32] Neoadjuvant chemotherapy for muscle-invasive bladder cancer: Complications and impact on cystectomy [J].

Neuzillet, Y. .

PROGRES EN UROLOGIE, 2015, 25 (09) :555-556

[33] DELAYS IN CYSTECTOMY FOR PATIENTS WITH MUSCLE-INVASIVE BLADDER CANCER [J].

Chu, A. ;

Holt, S. ;

Gore, J. .

JOURNAL OF INVESTIGATIVE MEDICINE, 2018, 66 (01) :75-75

[34] Cisplatin, Gemcitabine, and Lapatinib as Neoadjuvant Therapy for Muscle-Invasive Bladder Cancer [J].

Narayan, Vivek ;

Mamtani, Ronac ;

Keefe, Stephen ;

Guzzo, Thomas ;

Malkowicz, S. Bruce ;

Vaughn, David J. .

CANCER RESEARCH AND TREATMENT, 2016, 48 (03) :1084-1091

[35] Comparison of outcomes between trimodal therapy and radical cystectomy in muscle-invasive bladder cancer: a propensity score matching analysis [J].

Kim, Yeon Joo ;

Byun, Sang Jun ;

Ahn, Hanjong ;

Kim, Choung-Soo ;

Hong, Beom-Sik ;

Yoo, Sangjun ;

Lee, Jae-Lyun ;

Kim, Young Seok .

ONCOTARGET, 2017, 8 (40) :68996-69004

[36] Propensity-score matched survival analysis of octogenarians with muscle-invasive bladder cancer: Chemoradiation compared to radical cystectomy [J].

Ganapathi, H. ;

Prabhakar, P. ;

Kulkarni, N. ;

Eldefrawy, A. ;

Caso, J. ;

Manoharan, M. .

EUROPEAN UROLOGY, 2023, 83 :S217-S218

[37] Neoadjuvant sintilimab combined with gemcitabine and cisplatin (GP) for muscle-invasive bladder cancer (MIBC) patients followed by selective bladder sparing surgery [J].

Tong, Z. ;

Fu, G. ;

Zhou, F. ;

Liu, X. ;

Xue, X. ;

Zhang, H. ;

Wang, Y. ;

Zhu, X. ;

Gao, Y. ;

Liu, L. ;

Bao, X. ;

Zheng, Y. ;

Fang, W. ;

Zhao, P. ;

Jin, B. .

ANNALS OF ONCOLOGY, 2023, 34 :S1210-S1210

[38] Phase II trial of neoadjuvant nivolumab with cisplatin and gemcitabine in muscle-invasive bladder cancer patients undergoing radical cystectomy. [J].

Gupta, Shilpa ;

Agarwal, Neeraj ;

Konety, Badrinath R. ;

Weight, Christopher J. ;

Thyagarajan, Bharat ;

Murugan, Paari J. ;

Koopmeiners, Joseph S. ;

Sonpavde, Guru .

JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)

[39] NEOADJUVANT VS ADJUVANT CHEMOTHERAPY FOR MUSCLE-INVASIVE BLADDER CANCER: A PROPENSITY MATCHED ANALYSIS [J].

Jue, Joshua ;

Koru-Sengul, Tulay ;

Miao, Feng ;

Velasquez, Maria ;

Savio, Luis ;

Alameddine, Mahmoud ;

Kroeger, Zachary ;

Ritch, Chad ;

Gonzalgo, Mark .

JOURNAL OF UROLOGY, 2018, 199 (04) :E313-E313

[40] Neoadjuvant versus adjuvant chemotherapy for muscle-invasive bladder cancer: a propensity matched analysis [J].

Jue, Joshua S. ;

Koru-Sengul, Tulay ;

Miao, Feng ;

Velasquez, Maria C. ;

Savio, Luis F. ;

Alameddine, Mahmoud ;

Kroeger, Zachary A. ;

Punnen, Sanoj ;

Parekh, Dipen J. ;

Ritch, Chad R. ;

Gonzalgo, Mark L. .

MINERVA UROLOGY AND NEPHROLOGY, 2021, 73 (05) :572-580

← 1 2 3 4 5 →